Articles dans des revues avec comité de lecture (48)
  1. 35. De Leener, A., Montanelli, L., Van Durme, J., Chae, H., Smits, G., Vassart, G., & Costagliola, S. (2006). Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. The Journal of clinical endocrinology and metabolism, 91(2), 555-562. doi:10.1210/jc.2005-1580
  2. 36. Ledent, C., Demeestere, I., Blum, D., Petermans, J., Hämäläinen, T., Smits, G., & Vassart, G. (2005). Premature ovarian aging in mice deficient for Gpr3. Proceedings of the National Academy of Sciences of the United States of America, 102(25), 8922-8926. doi:10.1073/pnas.0503840102
  3. 37. Urizar Andrieu, E., Montanelli, L., Loy, T., Bonomi, M., Swillens, S., Gales, C., Bouvier, M., Smits, G., Vassart, G., & Costagliola, S. (2005). Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO journal, 24(11), 1954-1964. doi:10.1038/sj.emboj.7600686
  4. 38. Delbaere, A., Smits, G., De Leener, A., Costagliola, S., & Vassart, G. (2005). Understanding ovarian hyperstimulation syndrome. Endocrine, 26(3), 285-290. doi:10.1385/ENDO:26:3:285
  5. 39. Daelemans, C., Smits, G., De Maertelaer, V., Costagliola, S., Englert, Y., Vassart, G., & Delbaere, A. (2004). Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. The Journal of clinical endocrinology and metabolism, 89(12), 6310-6315. doi:10.1210/jc.2004-1044
  6. 40. Montanelli, L., Van Durme, J., Smits, G., Bonomi, M., Rodien, P., Devor, E. J., Moffat-Wilson, K., Pardo, L., Vassart, G., & Costagliola, S. (2004). Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Molecular endocrinology, 18(8), 2061-2073. doi:10.1210/me.2004-0036
  7. 41. Smits, G., & Kajava, A. V. (2004). LRRC8 extracellular domain is composed of 17 leucine-rich repeats. Molecular immunology, 41(5), 561-562. doi:10.1016/j.molimm.2004.04.001
  8. 42. Montanelli, L., Delbaere, A., Di Carlo, C., Nappi, C., Smits, G., Vassart, G., & Costagliola, S. (2004). A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. The Journal of clinical endocrinology and metabolism, 89(4), 1255-1258. doi:10.1210/jc.2003-031910
  9. 43. Delbaere, A., Smits, G., Olatunbosun, O., Pierson, R., Vassart, G., & Costagliola, S. (2004). New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Human reproduction, 19(3), 486-489. doi:10.1093/humrep/deh124
  10. 44. Smits, G., Olatunbosun, O., Delbaere, A., Pierson, R., Vassart, G., & Costagliola, S. (2003). Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. The New England journal of medicine, 349(8), 760-766. doi:10.1056/NEJMoa030064
  11. 45. Smits, G., Campillo, M., Govaerts, C., Janssens, V., Richter, C., Vassart, G., Pardo, L., & Costagliola, S. (2003). Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO journal, 22(11), 2692-2703. doi:10.1093/emboj/cdg260
  12. 46. Smits, G., Govaerts, C., Nubourgh, I., Pardo, L., Vassart, G., & Costagliola, S. (2002). Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG. Molecular endocrinology, 16(4), 722-735.
    13. << Précédent 1 2 3 4 5 6 7 8 Suivant >>